
|Videos|January 22, 2019
Perioperative Immunotherapy the Future of HCC Treatment?
Author(s)Ahmed Kaseb, MD
Cancer Network spoke with Dr. Ahmed Kaseb about a phase II pilot trial of perioperative immunotherapy for resectable HCC and how the results could change future perioperative treatment of the disease.
Advertisement
Cancer Network spoke with Dr. Ahmed Kaseb about a phase II pilot trial of perioperative immunotherapy for resectable HCC and how the results could change future perioperative treatment of the disease.
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
Nab-Sirolimus Regimens Show Promise in HR+/HER2-Negative Breast Cancer
2
FDA Approves Narsoplimab for HSCT-Associated Thrombotic Microangiopathy
3
Ivosidenib Combo Shows Preliminary Activity in IDH1-Mutated AML
4
‘Seamlessly’ Integrating Bioimpedance Spectroscopy Into Clinical Workflows
5
































































































